464 related articles for article (PubMed ID: 38737201)
1. An overview on glycation: molecular mechanisms, impact on proteins, pathogenesis, and inhibition.
Uceda AB; Mariño L; Casasnovas R; Adrover M
Biophys Rev; 2024 Apr; 16(2):189-218. PubMed ID: 38737201
[TBL] [Abstract][Full Text] [Related]
2. A review on prevention of glycation of proteins: Potential therapeutic substances to mitigate the severity of diabetes complications.
Sarmah S; Roy AS
Int J Biol Macromol; 2022 Jan; 195():565-588. PubMed ID: 34920073
[TBL] [Abstract][Full Text] [Related]
3. Glycation of Lysozyme by Glycolaldehyde Provides New Mechanistic Insights in Diabetes-Related Protein Aggregation.
Mariño L; Maya-Aguirre CA; Pauwels K; Vilanova B; Ortega-Castro J; Frau J; Donoso J; Adrover M
ACS Chem Biol; 2017 Apr; 12(4):1152-1162. PubMed ID: 28257177
[TBL] [Abstract][Full Text] [Related]
4. Glycation Damage: A Possible Hub for Major Pathophysiological Disorders and Aging.
Fournet M; Bonté F; Desmoulière A
Aging Dis; 2018 Oct; 9(5):880-900. PubMed ID: 30271665
[TBL] [Abstract][Full Text] [Related]
5. Advanced Glycation End Products and Diabetes Mellitus: Mechanisms and Perspectives.
Khalid M; Petroianu G; Adem A
Biomolecules; 2022 Apr; 12(4):. PubMed ID: 35454131
[TBL] [Abstract][Full Text] [Related]
6. Implication of advanced glycation end products (Ages) and their receptor (Rage) on myocardial contractile and mitochondrial functions.
Neviere R; Yu Y; Wang L; Tessier F; Boulanger E
Glycoconj J; 2016 Aug; 33(4):607-17. PubMed ID: 27277623
[TBL] [Abstract][Full Text] [Related]
7. Naturally occurring inhibitors against the formation of advanced glycation end-products.
Peng X; Ma J; Chen F; Wang M
Food Funct; 2011 Jun; 2(6):289-301. PubMed ID: 21779567
[TBL] [Abstract][Full Text] [Related]
8. Aftermath of AGE-RAGE Cascade in the pathophysiology of cardiovascular ailments.
Wasim R; Mahmood T; Siddiqui MH; Ahsan F; Shamim A; Singh A; Shariq M; Parveen S
Life Sci; 2022 Oct; 307():120860. PubMed ID: 35940220
[TBL] [Abstract][Full Text] [Related]
9. Inhibitors of Advanced Glycation End Product (AGE) Formation and Accumulation.
Sourris KC; Watson A; Jandeleit-Dahm K
Handb Exp Pharmacol; 2021; 264():395-423. PubMed ID: 32809100
[TBL] [Abstract][Full Text] [Related]
10. Uremic Toxicity of Advanced Glycation End Products in CKD.
Stinghen AE; Massy ZA; Vlassara H; Striker GE; Boullier A
J Am Soc Nephrol; 2016 Feb; 27(2):354-70. PubMed ID: 26311460
[TBL] [Abstract][Full Text] [Related]
11. [Therapeutic intervention in diseases with advanced glycation end products in their pathogenesis].
Zuwała-Jagiełło J
Pol Merkur Lekarski; 2009 Aug; 27(158):152-6. PubMed ID: 19856885
[TBL] [Abstract][Full Text] [Related]
12. A review on mechanism of inhibition of advanced glycation end products formation by plant derived polyphenolic compounds.
Anwar S; Khan S; Almatroudi A; Khan AA; Alsahli MA; Almatroodi SA; Rahmani AH
Mol Biol Rep; 2021 Jan; 48(1):787-805. PubMed ID: 33389535
[TBL] [Abstract][Full Text] [Related]
13. A Glycation Angle to Look into the Diabetic Vasculopathy: Cause and Cure.
Ahmad S; Siddiqui Z; Rehman S; Khan MY; Khan H; Khanum S; Alouffi S; Saeed M
Curr Vasc Pharmacol; 2017; 15(4):352-364. PubMed ID: 28356033
[TBL] [Abstract][Full Text] [Related]
14. Pathologic role of dietary advanced glycation end products in cardiometabolic disorders, and therapeutic intervention.
Yamagishi S; Matsui T
Nutrition; 2016 Feb; 32(2):157-65. PubMed ID: 26602289
[TBL] [Abstract][Full Text] [Related]
15. Endogenous advanced glycation end products in the pathogenesis of chronic diabetic complications.
Mengstie MA; Chekol Abebe E; Behaile Teklemariam A; Tilahun Mulu A; Agidew MM; Teshome Azezew M; Zewde EA; Agegnehu Teshome A
Front Mol Biosci; 2022; 9():1002710. PubMed ID: 36188225
[TBL] [Abstract][Full Text] [Related]
16. An
Khanam A; Alouffi S; Rehman S; Ansari IA; Shahab U; Ahmad S
J Biomol Struct Dyn; 2021 Sep; 39(14):5209-5223. PubMed ID: 32772827
[TBL] [Abstract][Full Text] [Related]
17. Toxicity of advanced glycation end products (Review).
Kuzan A
Biomed Rep; 2021 May; 14(5):46. PubMed ID: 33786175
[TBL] [Abstract][Full Text] [Related]
18. The inhibitory effects of natural antioxidants on protein glycation as well as aggregation induced by methylglyoxal and underlying mechanisms.
Liu H; Huo X; Wang S; Yin Z
Colloids Surf B Biointerfaces; 2022 Apr; 212():112360. PubMed ID: 35131714
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic Interventions for Advanced Glycation-End Products and its Receptor- Mediated Cardiovascular Disease.
Prasad K; Tiwari S
Curr Pharm Des; 2017; 23(6):937-943. PubMed ID: 27719648
[TBL] [Abstract][Full Text] [Related]
20. Impact of Non-Enzymatic Glycation in Neurodegenerative Diseases: Role of Natural Products in Prevention.
Ahmad S; Farhan M
Adv Neurobiol; 2016; 12():125-51. PubMed ID: 27651252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
